Gautam Sethi
Medical Drive, 117 600
Singapore, Singapore
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 530 publications
Retraction notice to "Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers" [Biomedicine & Pharmacotherapy 181 (2024) 117714].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 19, 2026
Hyaluronic acid-engineered copper sulfide nanoparticles as immunomodulatory metal sulfide photothermal agents for macrophage-assisted osteosarcoma therapy.
Journal: Materials today. Bio
Published: June 16, 2026
Overcoming immune resistance through tumor microenvironment reprogramming: Emerging immunotherapeutic strategies and translational advances.
Journal: Biochemical pharmacology
Published: June 07, 2026
Microvesicle release drives cycles of mitophagy flux disruption and inflammatory amplification in sepsis-induced myocardial dysfunction.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 06, 2026
Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].
Journal: Materials today. Bio
Published: April 02, 2026
Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: March 30, 2026
Genistein and the immune system: experimental evidence, key challenges, and future perspectives.
Journal: Biochemical pharmacology
Published: March 05, 2026
Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.
Journal: Cell communication and signaling : CCS
Published: February 24, 2026
TRIM27-Cas9-loaded EVs suppress HCC proliferation and enhance responsiveness to anti-PD-1 therapy by promoting ACSL4-mediated ferroptosis.
Journal: Cell death and differentiation
Published: February 14, 2026
Remodeling of the tumor microenvironment in muscle-invasive bladder cancer: insights from single-cell and spatial transcriptomics after neoadjuvant immunochemotherapy.
Journal: Molecular cancer
Published: February 09, 2026
WDR72 Promotes Neuroblastoma Stemness and Progression by Sequestering TRIM31-Mediated Degradation of CBX8.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 27, 2026
Tumor-specific mechanisms and therapeutic strategies for overcoming immunotherapy resistance in advanced urological tumors.
Journal: Journal of advanced research
Published: January 27, 2026
Last Updated: 09/26/2026